Contributor: Special thanks to Stefano Nistri from the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
Based on the 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy.
Updated with ESC Congress 2015 sessions!
Webinars on this topic
2014 ESC webinar on "How the new ESC Guidelines on cardiomyopathies will change my practice?" Watch the recording.
Update - ESC Congress 2015 sessions
Topics in Focus
Session Title |
Slides |
Webcast |
Guidelines in Practice |
|
|
A hypertrophic cardiomyopathy patient with skeletal muscle weakness and visual impairment |
|
|
A hypertrophic cardiomyopathy patient with skeletal muscle weakness and visual impairment - What do the Guidelines say?
|
|
|
A hypertrophic cardiomyopathy patient with skeletal muscle weakness and visual impairment - Conclusion and take home message |
|
|
A hypertrophic cardiomyopathy patient with intermediate sudden cardiac death risk |
|
|
A hypertrophic cardiomyopathy patient with intermediate sudden cardiac death risk - What do the Guidelines say? |
|
|
A hypertrophic cardiomyopathy patient with intermediate sudden cardiac death risk. Conclusion and take home message |
|
|
Multimodality / hybrid imaging, other imaging |
|
|
Hypertrophic cardiomyopathy: Imaging guided management in recent ESC Guidelines |
|
|
Hypertrophic cardiomyopathy - What do the Guidelines say? Imaging guided management in recent ESC Guidelines |
|
|
Hypertrophic cardiomyopathy - Conclusion and take home message. Imaging guided management in recent ESC Guidelines
|
|
|
ESC Congress 2014 sessions
Part 1 - Overview of the ESC Guidelines 2014
Session Title |
Slides |
Webcast |
ESC Guidelines 2014 overview: Hypertrophic Cardiomyopathy |
|
|
ESC Guidelines: a systematic approach to the diagnosis of hypertrophic cardiomyopathy |
|
|
ESC Guidelines: guidelines for genetic testing in hypertrophic cardiomyopathy |
|
|
ESC Guidelines: recommended approach to the assessment and treatment of symptoms |
|
|
ESC Guidelines: new guidelines on sudden death prevention |
|
|
Myocardial disease in the 2014 ESC Guidelines on hypertrophic cardiomyopathy: what do the Guidelines say |
|
|
Meet the Guidelines Task Force II |
|
|
Part 2 - Topics in focus
Topics |
Session Title |
Slides |
Webcast |
Prognosis in hypertrophic cardiomyopathy
|
A new risk stratification algorythm for sudden cardiac death |
|
|
Is there a role for biomarkers |
|
|
Atrial fibrillation and stroke prevention |
|
|
The challenge of pregnancy in grown-up congenital heart disease and cardiomyopathy |
Pregnancy and heart disease |
|
|
Diagnostic challenges in cardiomyopathies |
Genetic diagnosis should always be considered for cardiomyopathy. PRO |
|
|
Genetic diagnosis should always be considered for cardiomyopathy. CONTRA |
|
|